| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AVEXIS INC COM | 1,035,657 | 24,501,000 | 16.12% | ||
| 2 | EDGE THERAPEUTICS INC | 1,933,582 | 17,692,000 | 11.64% | ||
| 3 | Ascendis Pharma | 721,152 | 13,377,000 | 8.80% | ||
| 4 | BIOCRYST PHARMACEUTICALS | 4,689,435 | 13,271,000 | 8.73% | ||
| 5 | DBV Technologies | 214,417 | 12,204,000 | 8.03% | ||
| 6 | REGENXBIO INC COM | 1,030,954 | 11,134,000 | 7.32% | ||
| 7 | HERON THERAPEUTICS INC | 405,901 | 7,708,000 | 5.07% | ||
| 8 | CYTOMX THERAPEUTICS INC COM | 577,831 | 7,429,000 | 4.89% | ||
| 9 | COHERUS BIOSCIENCES INC COM | 259,259 | 5,504,000 | 3.62% | ||
| 10 | AKARI THERAPEUTICS PLC | 369,490 | 5,173,000 | 3.40% | ||
| 11 | AXOVANT SCIENCES LTD | 429,590 | 4,932,000 | 3.24% | ||
| 12 | ALCOBRA LTD | 1,130,500 | 4,285,000 | 2.82% | ||
| 13 | LIPOCINE INC NEW | 420,000 | 4,263,000 | 2.80% | ||
| 14 | ARCA biopharma Inc | 1,078,932 | 3,744,000 | 2.46% | ||
| 15 | BEIGENE LTD | 119,000 | 3,488,000 | 2.29% | ||
| 16 | Cynapsus Therapeutics Inc | 253,345 | 3,073,000 | 2.02% | ||
| 17 | OCERA THERAPEUTICS INC | 948,372 | 2,788,000 | 1.83% | ||
| 18 | GLOBAL BLOOD THERAPEUTICS IN COM | 170,312 | 2,701,000 | 1.78% | ||
| 19 | STEMLINE THERAPEUTICS INC | 315,980 | 1,472,000 | 0.97% | ||
| 20 | AVALANCHE BIOTECHNOLOGIES IN | 280,000 | 1,448,000 | 0.95% | ||
| 21 | ZAFGEN INC COM | 141,479 | 945,000 | 0.62% | ||
| 22 | ProNAi Therapeutics, Inc. | 130,798 | 882,000 | 0.58% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-017148, filed 2016.05.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
